Loading...
XSHG600380
Market cap2.93bUSD
Dec 25, Last price  
11.42CNY
1D
0.26%
1Q
8.97%
Jan 2017
27.03%
Name

Joincare Pharmaceutical Group Industry Co Ltd

Chart & Performance

D1W1MN
XSHG:600380 chart
P/E
14.83
P/S
1.29
EPS
0.77
Div Yield, %
1.57%
Shrs. gr., 5y
3.17%
Rev. gr., 5y
8.24%
Revenues
16.65b
-2.90%
2,345,798,3572,488,918,1192,076,203,6792,498,556,7272,938,487,3603,683,247,0604,472,857,5984,791,513,5305,849,960,9206,219,885,2017,417,906,2358,641,891,3769,721,544,23910,779,258,18711,203,963,98911,980,153,10913,521,605,76815,903,688,26617,142,753,06816,646,350,349
Net income
1.44b
-50.15%
97,263,412128,009,0420725,072,4840486,007,539740,046,667261,953,124169,521,951273,624,524354,238,756412,469,700451,415,1992,133,040,434699,410,8551,850,018,0102,578,466,4952,612,849,0382,894,096,0961,442,779,722
CFO
3.93b
-1.23%
241,705,413363,129,421272,498,706429,263,438455,013,618605,663,1041,105,268,466650,356,523734,362,616635,518,849979,456,2261,264,582,8331,644,557,2671,870,376,0971,825,535,7992,312,447,6873,024,999,5922,563,089,0453,977,705,1393,928,909,609
Dividend
Jul 18, 20240.18 CNY/sh
Earnings
Jun 06, 2025

Profile

Joincare Pharmaceutical Group Industry Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and healthcare products primarily in China. The company offers chemical drug preparation products, including respiration, gastroenterology, anti-infection, gonadotropic, and psychiatric products; and traditional chinese drug preparation production, which includes anti-tumor and cold products. It also provides chemical APIs and intermediates; diagnostic reagents and equipment, including autoimmunity multiple detection platform and diagnostic kit for IgM; and healthcare products, which includes American ginseng tea and Jingxin menocare essence. In addition, the company engages in the wholesale and retail of skin care products, cosmetics, and other necessities. It offers its products in various forms, such as hormone tablets, oral liquids, and tablets. The company was founded in 1992 and is headquartered in Shenzhen, China.
IPO date
Jun 08, 2001
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
16,646,350
-2.90%
17,142,753
7.79%
15,903,688
17.62%
Cost of revenue
12,172,065
13,165,449
12,433,899
Unusual Expense (Income)
NOPBT
4,474,285
3,977,304
3,469,789
NOPBT Margin
26.88%
23.20%
21.82%
Operating Taxes
614,536
562,009
339,480
Tax Rate
13.73%
14.13%
9.78%
NOPAT
3,859,749
3,415,295
3,130,309
Net income
1,442,780
-50.15%
2,894,096
10.76%
2,612,849
1.33%
Dividends
(336,792)
(277,558)
(288,675)
Dividend yield
1.42%
1.30%
1.16%
Proceeds from repurchase of equity
(821,537)
(1)
BB yield
3.47%
0.00%
Debt
Debt current
2,076,159
2,189,128
2,610,061
Long-term debt
3,153,119
3,277,809
876,924
Deferred revenue
384,537
433,543
Other long-term liabilities
460,180
84,000
78,000
Net debt
(14,157,591)
(11,955,393)
(11,070,477)
Cash flow
Cash from operating activities
3,928,910
3,977,705
2,563,089
CAPEX
(1,130,149)
Cash from investing activities
(1,021,591)
Cash from financing activities
(1,936,644)
566,123
FCF
4,006,982
2,940,766
2,243,649
Balance
Cash
16,181,164
14,917,504
11,913,869
Long term investments
3,205,706
2,504,826
2,643,593
Excess cash
18,554,552
16,565,192
13,762,278
Stockholders' equity
20,428,080
20,145,722
18,026,751
Invested Capital
9,759,013
11,029,325
10,120,171
ROIC
37.13%
32.30%
34.26%
ROCE
15.66%
14.29%
14.40%
EV
Common stock shares outstanding
1,907,177
1,896,977
1,937,153
Price
12.43
10.10%
11.29
-12.07%
12.84
-7.69%
Market cap
23,706,215
10.69%
21,416,875
-13.90%
24,873,043
-8.59%
EV
18,432,253
18,359,890
22,161,883
EBITDA
5,528,379
4,815,006
4,090,243
EV/EBITDA
3.33
3.81
5.42
Interest
146,728
139,016
90,278
Interest/NOPBT
3.28%
3.50%
2.60%